STAGE 07 · MARKET

Launch, learn, and scale

Turn authorization into repeatable clinical practice through manufacturing, training, access, surveillance, and controlled improvement.

Typical horizonOngoing
Common capitalSeries B+ · revenue · strategic acquisition
Illustrative spendHighly program-dependent
RECOGNIZE THE STAGE

How to know you are here

Authorization or a defined market-entry route is in place
Manufacturing and quality release processes are operational
The focus is shifting to adoption, access, and real-world performance
READINESS LENSES

What must be managed together

Evidence

Real-world performance, adoption, training effectiveness, complaints, and post-market outcomes.

Regulatory

Registration, listing, complaint handling, vigilance, post-market surveillance, and controlled changes.

Capital

Series B+ · revenue · strategic acquisition. Highly program-dependent.

ACTION PLAN

Priorities for the next 90 days

  1. 01

    Complete manufacturing transfer and supply-chain controls

  2. 02

    Build role-specific clinical training and implementation support

  3. 03

    Monitor complaints, adoption barriers, and real-world performance

  4. 04

    Prioritize controlled changes using evidence and commercial impact

BEFORE YOU ADVANCE

Required outputs

  • Commercial launch-readiness plan
  • Training and implementation system
  • Post-market surveillance plan
  • Next-generation evidence roadmap
WATCH FOR

Common failure modes

  • Treating authorization as the finish line
  • Inconsistent implementation across sites
  • Uncontrolled product changes after launch
THE DECISION GATE

Can the product become safe, repeatable, economically sustainable clinical practice?

Do not advance because time or money has been spent. Advance when the evidence supports the decision.

Previous stageGenerate clinical evidence and secure authorizationReassessReturn to the Navigator

NEED A COMPANY-SPECIFIC ROADMAP?

Turn this orientation into a milestone plan.

SECUIA can connect product, evidence, regulatory, usability, and financing decisions around your actual technology.

Call SECUIA